Market revenue in 2021 | USD 8.8 million |
Market revenue in 2030 | USD 123.2 million |
Growth rate | 34.1% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.86% in 2021. Horizon Databook has segmented the Australia ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The country’s development in terms of R&D initiatives, start-up ecosystem, and technological advancements has led to increase in the adoption of AI-based solutions in the country. Although penetration of such solutions is low in the country as compared to other countries in the region, improvement in healthcare system and rising awareness are expected to be beneficial in increasing the overall market share of the country in the coming years.
In addition, the start-up ecosystem of the country is growing, mainly owing to funding opportunities and developing healthcare systems in the country. In addition, supportive government initiatives and increasing number of large pharmaceutical players entering into the country are expected to boost the market in the near future.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Australia ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account